Nov. 2016 – CRI Report

Research Report on Service Robot Industry in China, 2017-2021

admin — Fri, 17 Aug 2018 09:07:54 +0000

Description

Service robots are applied in non-manufacturing industries to serve people. They can be divided into personal, household and professional service robots by usage. Service robots are widely used in multiple fields such as home nursing, medical, logistics, cleaning, security, rescue, guardianship and military.

In contrast to industrial robots, service robots are closer to common consumers so the client groups are more extensive. Service robots possess similar properties to durable goods such as electronic and household appliance products. The service spots are diversified so service robots are rich both in varieties and functions accordingly. From this perspective, the market space of service robots is more extensive than that of industrial robots.

Labor costs in developed countries rise increasingly, and young people tend to be more reluctant to engage in low-end jobs such as cleaning, nursing and security. The insufficiency of such simple labors leads to huge market space for service robots.

With the improvement of economy and resident income, many people can afford purchasing service robots for household cleaning.

The global aging population results in a lot of problems and the demand of residents grows for social security, household services and nursing so service robots possess large development space as a favorable solution.

The upgrading of intelligent robots speeds up with more functions while the costs decline for the development of computers and microchips, which promotes the progress of the service robot industry.

The total sales volume of service robots exceeded 40,000 and that of personal together with household ones exceeded 5 million in the globe in 2015. Currently, there are hundreds of enterprises involved in the service robot field in the world. Among them, iRobot focuses on household service robots, Intuitive Surgical focuses on medical robots, Aldebaran SAS provides professional personal robots while Boston Dynamics mainly develops military robots. In recent years, giants such as Google, Amazon, Microsoft, Ali, Foxconn and Softbank started the layout in the service robot field for strategic advantages.

The information technology will deeply integrate with the service robot manufacturing industry. Meanwhile, service robots are expected to become a new generation of intelligent terminals as emerging consumption hotspots after computers and mobile phones.

Chinese government issued a series of supporting policies for the development of the service robot industry. In January 2015, China’s Ministry of Industry and Information Technology released the Promotion Plan for Deep Integration of Informationization and Industrialization in Raw Material Industry (2015-2018) to support the development of the robot industry. In May 2015, the State Council issued specific plan of Made in China 2025, in which service robots play a significant role.

According to the history of the service robot industry, unmanned planes, iRobots and education robots will take the lead in development. The domestic robot industry develops rapidly in China presently and a number of local enterprises emerge such as Ecovacs, Xrobot and BONA. Education robot brands such as UBTECH and UNISROBO spring up with the accelerating industrialization as well.

In general, the service robot market is expected to maintain high-speed development in the next few years. Meanwhile, investment opportunities exist for investors in various related industries to the service robot industry chain.

Through this report, readers can acquire the following information or even more:

-Supporting Polices of Chinese Government on Service Robots

-Supply and Demand Status of Service Robots in China

-Competition in Service Robot Market

-Major Manufacturers of Service Robots in China

-Major Driving Forces and Market Opportunities in China Service Robot Industry

-Prospect of Service Robot Industry

The following enterprises and people are recommended to purchase this report:

-Manufacturers of Service Robots

– Users of Service Robot

-Investors or Research Institutes Concerned About Service Robot Industry

The post Research Report on Service Robot Industry in China, 2017-2021 first appeared on CRI Report.

Global Interleukin 10 Pipeline Product Analysis Review Market Analysis

admin — Fri, 17 Aug 2018 09:01:27 +0000

Introduction:
Interleukin-10, human cytokine synthesis inhibitory factor (CSIF), is group of related proteins made by leukocytes and other body cells. It is an anti-inflammatory cytokine. IL-10 plays a key role in differentiation and function of a newly appreciated type of T cell, the T regulatory cell, which prominently control immune responses and tolerance. Interleukin-10 has 20 molecules in their pipeline developed by companies and universities.
Interleukin 10 Pipeline Product Analysis includes products such as AM-0010, ANV-103, BT-063, DEKAVIL/F8 IL10, EG-12, LEO-32731, MK-1966, PD-2244, XT-101, XT-150, Gene Therapy to Activate Interleukin 10 for Atherosclerosis, Gene Therapy to Activate Interleukin-10 for ALS, XT-150, Gene Therapy to Activate Interleukin 10 for Atherosclerosis, Gene Therapy to Activate Interleukin-10 for ALS, Biologic to Activate Glutamic Acid Decarboxylase and IL-10 for Type 1 Diabetes, Biologic to Target Gluten and IL-10 for Celiac Disease, Cell Therapy to Activate IL-10 for Autoimmune Myocarditis and Inflammation, Synthetic Peptides to Inhibit IL-10 and IFN Gamma for Cancer, and Viral Infections and Inflammatory Diseases.
Study objectives of Interleukin 10 Pipeline Product Analysis market:
• To provide a snapshot of the global therapeutic landscape for Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10).
• To review Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• To provide descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
• To determine the key players involved in Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics and enlists all their major and minor projects.
• To assess Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type.
Target Audience:
• Companies with Interleukin-10 products
• Government Research Laboratories
• Academic Universities/Institutes
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Medical Research Laboratories
Key Findings:
• The Interleukin-10 (IL-10) – Pipeline Review involves featured 18 products in pipeline.
• 9 products are in preclinical trials, 4 in phase II, 2 in phase I and 2 studies were discontinued due to tolerance issues.
Key Players:
• The leading market players in the global Interleukin 10 Pipeline Product Analysis include Pfizer Inc., Merck & Co., Inc, Biotest AG, BioMAS Ltd, EnGene Inc., Leo Pharma, Anvil Biosciences, Intrexon Corporation, P2D Biosciences, Xalud Therapeutics INC and others.

1 Report Prologue
2 Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Methodology
2.2.2 Assumptions
2.3 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising Launch of New Concepts by Key Manufacturers
4.2.2 Larger Patient Base
4.3 Restraints
4.3.1 Stringent Regulatory Guidelines for the Use of the Drugs
4.4 Mega Trends
4.4.1 Development of New Technology for the Treatment of Disease
4.4.2 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Value Chain Analysis
6 Stages of Clinical Trials
6.1 Preclinical Trial
6.2 Phase I Clinical Trial
6.3 Phase II Clinical Trial
6.4 Phase III Clinical Trial
6.5 Phase IV Clinical Trial
7 Interleukin 10 Pipeline Product Analysis, By Product
7.1 AM-0010
7.1.1 Product Description
7.1.2 Mechanism of Action
7.1.3 Clinical Trial Progress
7.2 ANV-103
7.2.1 Product Description
7.2.2 Mechanism of Action
7.2.3 Clinical Trial Progress
7.3 AS-101
7.3.1 Product Description
7.3.2 Mechanism of Action
7.3.3 Clinical Trial Progress
7.4 BT-063
7.4.1 Product Description
7.4.2 Mechanism of Action
7.4.3 Clinical Trial Progress
7.5 DEKAVIL/F8 IL10
7.5.1 Product Description
7.5.2 Mechanism of Action
7.5.3 Clinical Trial Progress
7.6 EG-12
7.6.1 Product Description
7.6.2 Mechanism of Action
7.6.3 Clinical Trial Progress
7.7 LEO-32731
7.7.1 Product Description
7.7.2 Mechanism of Action
7.7.3 Clinical Trial Progress
7.8 MK-1966
7.8.1 Product Description
7.8.2 Mechanism of Action
7.8.3 Clinical Trial Progress
7.9 PD-2244
7.9.1 Product Description
7.9.2 Mechanism of Action
7.9.3 Clinical Trial Progress
7.10 XT-101
7.10.1 Product Description
7.10.2 Mechanism of Action
7.10.3 Clinical Trial Progress
7.11 XT-150
7.11.1 Product Description
7.11.2 Mechanism of Action
7.11.3 Clinical Trial Progress
7.12 Gene Therapy to Activate Interleukin 10 for Atherosclerosis
7.12.1 Product Description
7.12.2 Clinical Trial Progress
7.13 Gene Therapy to Activate Interleukin-10 for ALS
7.13.1 Clinical Trial Progress
7.14 Biologic to Activate Glutamic Acid Decarboxylase and IL-10 for Type 1 Diabetes
7.14.1 Clinical Trial Progress
7.15 Biologic to Target Gluten and IL-10 for Celiac Disease
7.15.1 Clinical Trial Progress
7.16 Cell Therapy to Activate IL-10 for Autoimmune Myocarditis and Inflammation
7.16.1 Clinical Trial Progress
7.17 Synthetic Peptides to Inhibit IL-10 and IFN Gamma for Cancer, Viral Infections and Inflammatory Diseases
7.17.1 Clinical Trial Progress
8 Competitive Landscape
8.1 Acquisitions & Partnership
8.1.1 Pfizer Acquire Anacor
8.1.2 Merck Aquire IOmet
8.1.3 Takeda and EnGene Establish Strategic Alliance
9 Company Profile
9.1 Pfizer Inc.
9.1.1 Overview
9.1.2 Product Overview
9.1.3 Financials
9.1.4 Key Developments
9.2 Merck & Co., Inc.
9.2.1 Overview
9.2.2 Product Overview
9.2.3 Financials
9.2.4 Key Developments
9.3 Biotest AG
9.3.1 Overview
9.3.2 Product Overview
9.3.3 Financials
9.3.4 Key Developments
9.4 BioMAS Ltd.
9.4.1 Overview
9.4.2 Product Overview
9.4.3 Financials
9.4.4 Key Developments
9.5 EnGene Inc.
9.5.1 Overview
9.5.2 Product Overview
9.5.3 Financials
9.5.4 Key Developments
9.6 Leo Pharma
9.6.1 Overview
9.6.2 Product Overview
9.6.3 Financials
9.6.3 Financials
9.6.4 Key Developments
9.7 Anvil Biosciences
9.7.1 Overview
9.7.2 Product Overview
9.7.3 Financials
9.7.4 Key Developments
9.8 Intrexon Corporation
9.8.1 Overview
9.8.2 Product Overview
9.8.3 Financials
9.8.4 Key Developments
9.9 P2D Biosciences
9.9.1 Overview
9.9.2 Product Overview
9.9.3 Financials
9.9.4 Key Developments
9.10 Xalud Therapeutics INC.
9.10.1 Overview
9.10.2 Product Overview
9.10.3 Financials
9.10.4 Key Developments

The post Global Interleukin 10 Pipeline Product Analysis Review Market Analysis first appeared on CRI Report.

China Cross-border E-commerce Industry Overview, 2017-2021

admin — Fri, 17 Aug 2018 08:38:15 +0000

Description

Cross-border E-commerce refers to import and export activities of cross-border trade conducted through e-commerce methods by transaction subjects from different customs borders. It is mainly classified into B2B and B2C.

In B2B, commercial platforms of cross-border e-commerce are added into the traditional international trade for staple cross-border transactions through information presentation, credit guarantee and payment means, which is still traditional in nature. In B2C, the cross-border transaction is conducted from concentrated purchase of merchants, storage in bonded warehouse and overseas warehouse to terminal consumers through express delivery, which reduces the costs of intermediate links and promotes the retail business of cross-border e-commerce. B2C is a new type e-commerce trade, of which the growth exerts significant impact on traditional trade and logistics mode.

With the increasing disposable income per capita, China is experiencing a new round of consumption upgrade. According to estimation, the number of middle class families with an annual income of over CNY 120,000 will exceed 200 million by 2020. The demand of Chinese consumers for mid-end and high-end skin care products, mother and baby products and health care products increases while most domestic products are inferior in quality but high in prices. Therefore, cross-border e-commerce platforms satisfy the import need of such domestic consumers for foreign goods.

The platforms of B2B and B2C emerge rapidly with the development of cross-border e-commerce industry in China from 2014. Leading enterprises in the e-commerce market such as Alibaba.com and JD.com together with some non e-commerce enterprises such as NetEase all step into the cross-border e-commerce field. In addition, some logistics and payment platforms start the layout of cross-border e-commerce as well. Meanwhile, global e-commerce enterprises such as Amazon.cn enter the cross-border e-commerce market in China with integrated supplier resources, and many overseas e-commerce websites open the business of direct delivery to China.

In 2015, the import origins of top 10 cross-border e-commerce products in China included the U.S.A., Japan, Germany, South Korea, Australia, Holland, France, the U.K., Italy and New Zealand, of which the products are preferred by Chinese consumers. According to CRI, Chinese consumers purchased commodities from 3 countries by average per capita through cross-border e-commerce in 2016, of which the most active consumers purchased commodities from 20 countries. The cross-border e-commerce industry provides selectivity freedom to Chinese consumers towards global products.

In terms of import categories, three major categories including mother and baby products, cosmetics for personal care and nutrition health products pull the import of cross-border e-commerce retails. Generally, cross-border e-commerce becomes the major new channel for Chinese consumers to purchase these products with the improving requirements on qualities of health and safe products. For example, infant formula sold on cross-border e-commerce platforms exerts great impact on the domestic industry.

Chinese government presents ambivalence towards the policy formulation concerning the cross-border e-commerce industry. On one hand, it energetically supports the cross-border e-commerce and issues preferential policies for less product smuggling, better development of Chinese economy and more tax with more employment. On the other hand, the emerging cross-border e-commerce exerts great impact on traditional import industry leading to less tax and value added tax revenue so Chinese government has to enhance the supervision and regulate the tax rate to suppress the excessively rapid expansion of cross-border e-commerce. Such policy ambivalence will impact the cross-border e-commerce industry. However, commodities sold on cross-border e-commerce platforms are superior to that of domestic ones or imported ones through normal channels in terms of prices and quality so it presents a positive development trend in general.

The total import and export value of commodity trade was CNY 24.59 trillion in China in 2015 decreasing by 7% compared to 2014. Meanwhile, the import value was CNY 10.45 trillion decreasing by 13.2% YOY. It is estimated that the foreign trade presents a negative trend with huge downward pressure in China in the next few years. However, the growth rate of cross-border e-commerce surpasses that of the import and export of commodity trade with an increasing penetration rate in China. The trade value of cross-border e-commerce reached CNY 4.8 trillion increasing by 28% YOY in China in 2015 and it is expected to exceed CNY 6 trillion in 2016. According to estimation, the trade value of cross-border e-commerce will exceed CNY 14 trillion by 2020 with the CAGR reaching 20% from 2015 to 2021.

Through this report, readers can acquire the following information or even more:

-Development Environment of Cross-border E-commerce Industry in China

-Supply and Demand Status of Cross-border E-commerce in China

-Market Competition of Cross-border E-commerce in China

-Major Cross-border E-commerce Enterprises and Their Operation Status in China

-Major Driving Forces and Market Opportunities in China Cross-border E-commerce Industry

-Risks and Challenges in China Cross-border E-commerce Industry

-Prediction on Market Scale of Cross-border E-commerce in China

Table of Contents

1 Relevant Concepts of Cross-border E-commerce Industry

1.1 Definition and Classification of Cross-border E-commerce

1.1.1 Definition of Cross-border E-commerce

1.1.2 Classification of Cross-border E-commerce

1.2 Parameters and Assumptions of the Report

1.2.1 Assumption Base

1.2.2 Data Sources

1.3 About CRI

2 Analysis on Cross-border E-commerce Industry in China, 2011-2016

2.1 Development Environment of Cross-border E-commerce Industry in China

2.1.1 Economic Environment of Cross-border E-commerce

2.1.2 Policy Environment of Cross-border E-commerce

2.1.3 Social Environment of Cross-border E-commerce

2.1.4 Technical Environment of Cross-border E-commerce

2.2 Analysis on Supply and Demand of Cross-border E-commerce

2.2.1 Analysis on Consumption Groups of Cross-border E-commerce

2.2.2 Analysis on Market Size of Cross-border E-commerce in China, 2011-2020

3 Competition Status of Cross-border E-commerce Industry in China, 2011-2016

3.1 Barriers to Entry of Cross-border E-commerce Industry in China

3.1.1 Policy Barriers of Cross-border E-commerce

3.1.2 Talent Barriers of Cross-border E-commerce

3.1.3 Brand barriers of Cross-border E-commerce

3.1.4 Logistics Barriers of Cross-border E-commerce

3.2 Competition Structure of Cross-border E-commerce Industry in China

3.2.1 Bargaining Ability of Cross-Border E-commerce Suppliers

3.2.2 Bargaining Ability of Cross-Border E-commerce Consumers

3.2.3 Internal Competition of Cross-border E-commerce Industry

3.2.4 Potential Entrants in Cross-border E-commerce Industry

3.2.5 Substitutes of Cross-border E-commerce

4 Analysis on Major Cross-border E-commerce Enterprises in China, 2013-2017

4.1 B2C Cross-border E-commerce

4.1.1 Tmall.com

4.1.2 Amazon.cn

4.1.3 JD Worldwide

4.1.4 VIP.com

4.1.5 Ymatou.com

4.1.6 KAOLA.com

4.2 B2B Cross-border E-commerce

4.2.1 DHgate.com

4.2.2 Alibaba.com

4.2.3 Osell.com

5 Analysis on Costs and Prices in China Cross-border E-commerce Industry, 2015-2017

5.1 Analysis on Costs of Cross-border E-commerce in China

5.2 Analysis on Sales Prices of Cross-border E-commerce Products in China

6 Prediction on Development of Cross-border E-commerce Industry in China, 2017-2021

6.1 Factors Influencing the Development of Cross-border E-commerce Industry

6.1.1 Major Driving Forces and Market Opportunities in Cross-border E-commerce Industry

6.1.2 Risks and Challenges in China Cross-border E-commerce Industry

6.2 Forecast on Supply of Cross-border E-commerce Industry in China, 2017-2021

6.2.1 Forecast on Quantity of Cross-border E-commerce in China

6.2.2 Prediction on Product Structure of Cross-border E-commerce

6.3 Forecast on Demand for Cross-border E-commerce in China, 2017-2021

Selected Charts

Chart Status of China Export to Major Global Economic Entities, 2015-2016

Chart Policies Concerning Cross-border E-commerce Issued by Chinese Government

Chart Trade Value of Cross-border E-commerce in China, 2011-2020

Chart Trading Amount of Tmall.com, 2014-2020

Chart Trading Amount of Amazon.cn, 2015-2020

Chart Trading Amount of JD.com, 2015-2020

Chart Trading Amount of KAOLA.com, 2015-2020

Chart Layout of Enterprises in China Cross-border E-commerce Market

Chart Layout of Third Party Service Enterprises in Cross-border E-commerce Market

Chart Forecast on Market Size of Cross-border E-commerce in China, 2017-2021

The post China Cross-border E-commerce Industry Overview, 2017-2021 first appeared on CRI Report.